Last reviewed · How we verify

NCT07443345

Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With Preeclampsia

Recruiting now Last updated 11 March 2026
What this trial tests

trial in Preecalmpsia in 52 participants. Currently enrolling.

Timeline
9 March 2026
Primary endpoint
30 December 2026
31 December 2026

Quick facts

Lead sponsorCairo University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment52
Start date9 March 2026
Primary completion30 December 2026
Estimated completion31 December 2026
Sites1 location across Egypt

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 40, female only, with Preecalmpsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preeclampsia with severe features remains a leading contributor to maternal morbidity and mortality, particularly in low- and middle-income countries. It is defined by hypertension and involvement of multiple organ systems, including renal, hepatic, hematologic, and neurologic pathways. The interplay of endothelial dysfunction, capillary leakage, and disrupted fluid balance in these patients increases their susceptibility to perioperative pulmonary complications. Although respiratory complications in preeclampsia are clinically significant, the true incidence of postoperative diaphragmatic dysfunction in women with severe disease is not well established. Existing literature largely emphasizes general respiratory failure, pulmonary edema, or the need for mechanical ventilation, rather than specifically evaluating diaphragmatic performance with objective methods such as ultrasound. The current study sought to determine the incidence and identify risk factors for postoperative diaphragmatic dysfunction in women with severe preeclampsia following cesarean delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07443345.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing